--- title: "《欧股》泛欧 Stoxx600 平安夜平收 诺和诺德飙 9%" description: "平安夜交易日缩短,欧洲股市周三小幅变动。泛欧 Stoxx600 指数收市无升跌。诺和诺德首个 GLP-1 片剂已获得美国食品药物管理局批准,该股欧洲股价大升逾 9%。英国富时 100 指数收跌 18 点或 0.2% 至 9,870 点。德国 DAX 指数收升 56 点或 0.2%,报 24,340 点。法国 CAC 40 指数收跌少于 1 点,报 8,103 点。" type: "news" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/270751625.md" published_at: "2025-12-24T20:10:15.000Z" --- # 《欧股》泛欧 Stoxx600 平安夜平收 诺和诺德飙 9% > 平安夜交易日缩短,欧洲股市周三小幅变动。泛欧 Stoxx600 指数收市无升跌。诺和诺德首个 GLP-1 片剂已获得美国食品药物管理局批准,该股欧洲股价大升逾 9%。英国富时 100 指数收跌 18 点或 0.2% 至 9,870 点。德国 DAX 指数收升 56 点或 0.2%,报 24,340 点。法国 CAC 40 指数收跌少于 1 点,报 8,103 点。 平安夜交易日缩短,欧洲股市周三小幅变动。泛欧 Stoxx600 指数收市无升跌。 诺和诺德首个 GLP-1 片剂已获得美国食品药物管理局批准,该股欧洲股价大升逾 9%。 英国富时 100 指数收跌 18 点或 0.2% 至 9,870 点。德国 DAX 指数收升 56 点或 0.2%,报 24,340 点。法国 CAC 40 指数收跌少於 1 点,报 8,103 点。 ### Related Stocks - [NVO.US - 诺和诺德公司](https://longbridge.com/zh-CN/quote/NVO.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Novo Nordisk Confirms Receipt Of “Untitled Letter” From FDA On Wegovy Pill Television Commercial | Novo Nordisk A/S :NOVO NORDISK: CONFIRM THAT NOVO NORDISK RECEIVED AN “UNTITLED LETTER” FROM FDA CONCERNING A TELEVISION | [Link](https://longbridge.com/zh-CN/news/275349213.md) | | Berenberg Bank Reaffirms Their Buy Rating on Novo Nordisk (0QIU) | Berenberg Bank analyst Kerry Holford has reaffirmed a Buy rating on Novo Nordisk (0QIU) with a price target of DKK360.00 | [Link](https://longbridge.com/zh-CN/news/275719942.md) | | Novo Nordisk CFO Karsten Munk Knudsen Sells Shares Worth Over DKK 8.3 Million | Novo Nordisk A/S announced that CFO Karsten Munk Knudsen sold 26,246 shares for DKK 8.3 million at DKK 315.60 each and 3 | [Link](https://longbridge.com/zh-CN/news/275652909.md) | | Novo Nordisk to Manufacture Wegovy in Ireland Facility | Novo Nordisk to Manufacture Wegovy in Ireland Facility | [Link](https://longbridge.com/zh-CN/news/275789396.md) | | Savvy Advisors Inc. Purchases 22,138 Shares of Novo Nordisk A/S $NVO | Savvy Advisors Inc. increased its stake in Novo Nordisk A/S by 83.0% in Q3, acquiring 22,138 shares, bringing its total | [Link](https://longbridge.com/zh-CN/news/275761183.md) | --- > **免责声明**:本文内容仅供参考,不构成任何投资建议。